We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+10.58%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.66B
AUM Growth
+$753M
(+13%)
Cap. Flow
+$191M
Cap. Flow
% of AUM
2.88%
Top 10 Holdings %
Top 10 Hldgs %
11.44%
Holding
1,143
New
233
Increased
309
Reduced
379
Closed
210
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$53.8M |
| 2 |
Starbucks
SBUX
|
+$50.2M |
| 3 |
McKesson
MCK
|
+$34.2M |
| 4 |
Pfizer
PFE
|
+$28.7M |
| 5 |
Deere & Co
DE
|
+$25.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.9M |
| 2 |
Comcast
CMCSA
|
+$41.5M |
| 3 |
Ross Stores
ROST
|
+$40.2M |
| 4 |
LSI
LSI CORPORATION
LSI
|
+$39.6M |
| 5 |
ExxonMobil
XOM
|
+$37.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Industrials | 13.75% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Financials | 11.72% |
| 5 | Healthcare | 11.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Innodata
INOD
$1.83B
| $118K | ﹤0.01% |
48,353
-16,894
| -26% | -$41.2K |
|
|
MEET
902
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $115K | ﹤0.01% |
+62,900
| New | +$117K |
|
|
IDXG
903
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $114K | ﹤0.01% |
238
-148
| -38% | -$72.3K |
|
904
Build-A-Bear
BBW
$423M
| $113K | ﹤0.01% |
15,031
-36,488
| -71% | -$295K |
|
|
FRF
905
DELISTED
FORTEGRA FINL CORP COM STK (DE)
FRF
| $112K | ﹤0.01% |
13,572
-2,740
| -17% | -$21.3K |
|
|
GRT
906
DELISTED
GLIMCHER REALTY TRUST
GRT
| $108K | ﹤0.01% |
+11,500
| New | +$113K |
|
|
ZIPR
907
DELISTED
ZIP REALTY, INC
ZIPR
| $107K | ﹤0.01% |
+19,100
| New | +$108K |
|
|
OMN
908
DELISTED
OMNOVA Solutions Inc.
OMN
| $106K | ﹤0.01% |
11,600
-21,836
| -65% | -$187K |
|
909
Codexis
CDXS
$135M
| $105K | ﹤0.01% |
74,767
-51,659
| -41% | -$80.7K |
|
|
OCLR
910
DELISTED
Oclaro Inc.
OCLR
| $103K | ﹤0.01% |
+41,400
| New | +$88.5K |
|
911
American Superconductor
AMSC
$1.48B
| $97K | ﹤0.01% |
5,927
-41,593
| -88% | -$775K |
|
|
BIRT
912
DELISTED
Actuate Corp
BIRT
| $95K | ﹤0.01% |
12,300
-76,400
| -86% | -$586K |
|
|
MATR
913
DELISTED
Mattersight Corp.
MATR
| $94K | ﹤0.01% |
+19,600
| New | +$88.6K |
|
914
First Busey Corp
BUSE
$2.52B
| $89K | ﹤0.01% |
+5,100
| New | +$84.5K |
|
|
WSTL
915
DELISTED
Westell Technologies Inc
WSTL
| $89K | ﹤0.01% |
5,479
-12,975
| -70% | -$196K |
|
916
BlueLinx
BXC
$455M
| $87K | ﹤0.01% |
+4,470
| New | +$79.8K |
|
|
ABCD
917
DELISTED
Cambium Learning Group, Inc.
ABCD
| $69K | ﹤0.01% |
41,373
-3,300
| -7% | -$4.84K |
|
|
FOLD
918
DELISTED
Amicus Therapeutics
FOLD
| $68K | ﹤0.01% |
28,912
-106,134
| -79% | -$233K |
|
919
Ultralife
ULBI
$88.3M
| $65K | ﹤0.01% |
18,256
-1,500
| -8% | -$5.6K |
|
|
IKAN
920
DELISTED
IKANOS COMMUNICATIONS INC COM STK NEW (DE)
IKAN
| $64K | ﹤0.01% |
5,333
-1,160
| -18% | -$14.4K |
|
921
Altimmune
ALT
$539M
| $61K | ﹤0.01% |
109
-31
| -22% | -$18.5K |
|
|
ONCT
922
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $61K | ﹤0.01% |
+27
| New | +$61.8K |
|
|
IMN
923
DELISTED
Imation
IMN
| $58K | ﹤0.01% |
12,433
-101,758
| -89% | -$443K |
|
|
RSYS
924
DELISTED
Radisys Corp
RSYS
| $55K | ﹤0.01% |
23,935
-79,064
| -77% | -$210K |
|
|
SUMR
925
DELISTED
Summer Infant, Inc.
SUMR
| $50K | ﹤0.01% |
3,076
-3,632
| -54% | -$78.9K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2013 Portfolio in Review
As of Q4 2013, Jacobs Levy Equity Management held 1,143 positions worth $6.66B, up 13% from $5.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management's Q4 2013 filing shows 233 new, 309 increased, 379 reduced and 210 closed positions. Its largest new stake was Deere & Co: 305,510 shares worth $27.9M. The largest sale was Visa, an estimated $49.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2013 buy was Deere & Co: 305,510 shares worth $27.9M.
- Jacobs Levy Equity Management added most to Amgen in Q4 2013, an estimated $53.8M increase.
- Jacobs Levy Equity Management's biggest Q4 2013 reduction was Visa, cutting an estimated $49.9M.
- Jacobs Levy Equity Management fully exited LSI CORPORATION in Q4 2013, selling an estimated $39.6M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $6.66B portfolio in Q4 2013.
- Jacobs Levy Equity Management opened 233 new positions and closed 210 in Q4 2013.
- Jacobs Levy Equity Management's portfolio value rose 13% quarter-over-quarter to $6.66B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2013, filed 14 Feb 2014.